Cargando…
Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
Imaging or tissue biomarker evidence has been introduced into the core diagnostic pathway for Alzheimer’s disease (AD). PET using (18)F-labelled beta-amyloid PET tracers has shown promise for the early diagnosis of AD. However, most studies included only small numbers of participants and no consensu...
Autores principales: | Morris, Elizabeth, Chalkidou, Anastasia, Hammers, Alexander, Peacock, Janet, Summers, Jennifer, Keevil, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700091/ https://www.ncbi.nlm.nih.gov/pubmed/26613792 http://dx.doi.org/10.1007/s00259-015-3228-x |
Ejemplares similares
-
A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer’s Disease
por: Fantoni, Enrico R., et al.
Publicado: (2018) -
Amyloid-Targeting PET Tracer [(18)F]Flutemetamol Accumulates in Atherosclerotic Plaques
por: Hellberg, Sanna, et al.
Publicado: (2019) -
Preclinical and clinical study on [(18)F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease
por: Xu, MiaoMiao, et al.
Publicado: (2021) -
High Correlation of Static First-Minute-Frame (FMF) PET Imaging after (18)F-Labeled Amyloid Tracer Injection with [(18)F]FDG PET Imaging
por: Seiffert, Alexander P., et al.
Publicado: (2021) -
Comparison of New Tau PET-Tracer Candidates With [(18)F]T808 and [(18)F]T807
por: Declercq, Lieven, et al.
Publicado: (2016)